================================================================================
                    ATTENDING PHYSICIAN STATEMENT (APS)
                    Life Insurance Medical Evaluation
================================================================================

REPORT DATE: January 7, 2026
DOCUMENT ID: APS-POC-003

--------------------------------------------------------------------------------
PATIENT INFORMATION
--------------------------------------------------------------------------------
Patient Name:     James Wilson
Date of Birth:    11/08/1962
Gender:           Male
Medical Record #: MRN-334456

--------------------------------------------------------------------------------
EXAMINING PHYSICIAN
--------------------------------------------------------------------------------
Physician Name:   Dr. David Thompson, MD, FACC
Practice:         Advanced Cardiology Associates
NPI:              5432167890

--------------------------------------------------------------------------------
CLINICAL NARRATIVE
--------------------------------------------------------------------------------
Patient presents for cardiovascular follow-up and life insurance evaluation.
Mr. Wilson is a 63-year-old male with significant cardiac history including
acute ST-elevation myocardial infarction (STEMI) in March 2023 involving
the left anterior descending artery (LAD). He underwent emergent percutaneous
coronary intervention (PCI) with drug-eluting stent placement.

Post-MI course complicated by reduced left ventricular function. Most recent
echocardiogram (October 2025) demonstrates LVEF of 40% (reduced from 55% pre-MI).
Patient reports New York Heart Association Class II symptoms with dyspnea on
moderate exertion such as climbing two flights of stairs.

Patient has history of poorly controlled Type 2 Diabetes with recent HbA1c of
9.2%. He admits to inconsistent medication compliance, particularly with his
statin due to reported muscle aches.

Continued cigarette smoking despite counseling - currently 1 pack per day.
Reports high stress at work and difficulty following dietary recommendations.

--------------------------------------------------------------------------------
ACTIVE MEDICAL CONDITIONS
--------------------------------------------------------------------------------
  - Coronary Artery Disease s/p STEMI (March 2023) - LAD territory
  - Ischemic Cardiomyopathy with reduced LVEF (40%)
  - Type 2 Diabetes Mellitus - poorly controlled
  - Essential Hypertension
  - Hyperlipidemia - suboptimally treated
  - Current tobacco use (1 PPD x 35 years)
  - Obesity (BMI 34)

--------------------------------------------------------------------------------
CURRENT MEDICATIONS
--------------------------------------------------------------------------------
  - Aspirin 81mg daily
  - Clopidogrel 75mg daily (dual antiplatelet therapy)
  - Metoprolol succinate 100mg daily
  - Lisinopril 40mg daily
  - Atorvastatin 80mg daily (reports non-compliance)
  - Metformin 1000mg twice daily
  - Glipizide 10mg twice daily
  - Empagliflozin 25mg daily
  - Furosemide 20mg daily

--------------------------------------------------------------------------------
SURGICAL HISTORY
--------------------------------------------------------------------------------
  - PCI with DES to LAD (March 2023)
  - Cardiac catheterization (March 2023) - 90% LAD stenosis
  - Appendectomy (1995)

--------------------------------------------------------------------------------
SOCIAL HISTORY
--------------------------------------------------------------------------------
  Tobacco Use:    Current smoker (1 PPD x 35 years = 35 pack-years)
  Alcohol Use:    Heavy (4-5 drinks daily, including weekdays)
  Occupation:     Accountant (sedentary, high stress)
  Exercise:       Minimal due to dyspnea

--------------------------------------------------------------------------------
RECENT LABORATORY VALUES (November 2025)
--------------------------------------------------------------------------------
  - HbA1c: 9.2% (poorly controlled, target <7%)
  - Fasting Glucose: 198 mg/dL (elevated)
  - Total Cholesterol: 245 mg/dL (elevated)
  - LDL: 142 mg/dL (above goal of <70 for CAD)
  - HDL: 34 mg/dL (low)
  - Triglycerides: 345 mg/dL (elevated)
  - BNP: 385 pg/mL (elevated, indicating cardiac stress)
  - GFR: 58 mL/min (Stage 3a CKD)
  - Creatinine: 1.4 mg/dL

--------------------------------------------------------------------------------
CARDIAC TESTING
--------------------------------------------------------------------------------
  Echocardiogram (October 2025):
    - LVEF: 40% (reduced)
    - Anterior wall hypokinesis
    - Mild mitral regurgitation
    - Left atrial enlargement
    
  Stress Test (September 2025):
    - Terminated early due to dyspnea at 5 METs
    - No ischemic ECG changes
    - Unable to achieve target heart rate

--------------------------------------------------------------------------------
PHYSICAL EXAMINATION
--------------------------------------------------------------------------------
  Vital Signs:
    - Blood Pressure: 152/94 mmHg (uncontrolled)
    - Heart Rate: 72 bpm
    - Height: 71 inches
    - Weight: 248 lbs
    - BMI: 34.6

  General: Obese male, appears older than stated age
  Cardiovascular: Irregular rhythm (occasional PVCs), S4 gallop present
  Respiratory: Bibasilar crackles
  Extremities: 1+ bilateral lower extremity edema
  Skin: Tobacco staining on fingers

--------------------------------------------------------------------------------
ASSESSMENT AND PLAN
--------------------------------------------------------------------------------
63-year-old male with SIGNIFICANT cardiovascular risk profile:

HIGH RISK FACTORS:
1. Recent MI (< 3 years) with reduced LVEF 40% (HIGH RISK per underwriting criteria)
2. Current heavy smoker (35 pack-years) - REFUSES cessation
3. Poorly controlled Type 2 Diabetes (HbA1c 9.2%)
4. Medication non-compliance (statin)
5. Heavy alcohol use
6. Stage 3a CKD (GFR 58)
7. Uncontrolled hypertension despite treatment
8. Low functional capacity (5 METs on stress test)

This patient presents MULTIPLE HIGH-RISK criteria for life insurance underwriting.
The combination of recent MI with reduced EF, ongoing tobacco use, and poor
metabolic control significantly increases mortality risk.

Prognosis: Guarded. Five-year cardiovascular event risk is substantially elevated.

RECOMMENDATION: HIGH RISK classification. Consider decline or significant rating.

Plan:
- Strongly counsel smoking cessation (patient declined)
- Optimize heart failure medications
- Consider ICD evaluation given LVEF 40%
- Refer to cardiac rehabilitation (patient previously declined)
- Endocrinology referral for diabetes management
- Recheck labs in 6 weeks

--------------------------------------------------------------------------------
PHYSICIAN ATTESTATION
--------------------------------------------------------------------------------
I certify this information is accurate and complete.

Dr. David Thompson, MD, FACC
Date: January 7, 2026

================================================================================
                         END OF ATTENDING PHYSICIAN STATEMENT
================================================================================
